← back to search

Ville N. Pimenoff

Karolinska Institutet · SE
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Cervical Cancer and HPV Research, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, and Hepatitis B Virus Studies.
h-index
20
citations
1,240
works
74
NIH funding
primary concept
email

Recent publications

Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study
npj Vaccines 2024cited by 5position: middledoi
Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts
Cell Host & Microbe 2023cited by 37position: firstdoi
<scp>HPV16 E6</scp>‐antibody associated risk of oropharyngeal cancer increases by calendar‐time: A nested case‐control study
International Journal of Cancer 2023cited by 1position: middledoi
Meta-Analysis and Validation of a Colorectal Cancer Risk Prediction Model Using Deep Sequenced Fecal Metagenomes
Cancers 2022cited by 39position: middledoi
Assessing the risk of cervical neoplasia in the <scp>post‐HPV</scp> vaccination era
International Journal of Cancer 2022cited by 36position: middledoi
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial
PLoS Medicine 2021cited by 23position: middledoi
Gut microbiome diversity detected by high-coverage 16S and shotgun sequencing of paired stool and colon sample
Scientific Data 2020cited by 95position: lastdoi
Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied
The Journal of Infectious Diseases 2020cited by 57position: middledoi
Long‐term follow‐up of human papillomavirus type replacement among young pregnant Finnish females before and after a community‐randomised <scp>HPV</scp> vaccination trial with moderate coverage
International Journal of Cancer 2020cited by 20position: middledoi
Population-Based Human Papillomavirus Serosurvey Reveals HPV16/18 Herd Effect But No Clear Type-Replacement in Unvaccinated Females 6 Years Post Gender-Neutral Vaccination in a Cluster Randomised Trial
SSRN Electronic Journal 2019cited by 0position: middledoi
Moderate Coverage Vaccination Eradicates Oncogenic Human Papillomaviruses if a Gender-Neutral Strategy is Applied
SSRN Electronic Journal 2019cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matti Lehtinen · Tampere University9 papers (2019–2024)Joakim Dillner · Regional Cancer Center8 papers (2019–2024) · 8 papers (2019–2024)Penelope Gray · Karolinska Institutet6 papers (2019–2024)Tapio Luostarinen · Finnish Cancer Registry5 papers (2019–2023)Helena Faust · Medical Products Agency4 papers (2019–2024)Simopekka Vänskä · Finnish Institute for Health and Welfare3 papers (2020–2021) · 3 papers (2020–2024) · 3 papers (2019–2024)Hanna Kann · Karolinska Institutet3 papers (2020–2024)Vı́ctor Moreno · Hospital Universitario de Móstoles2 papers (2020–2022)Karolina Louvanto · McGill University Health Centre2 papers (2022–2023) · 2 papers (2019–2020) · 2 papers (2019–2020)­Eero Pukkala · Cancer Registry of Norway2 papers (2019–2020)Mireia Obón‐Santacana · Universitat de Barcelona2 papers (2020–2022)Tim Waterboer · German Cancer Research Center2 papers (2023–2024)Ana García‐Rodríguez · Universitat de Barcelona2 papers (2020–2022) · 2 papers (2019–2020) · 2 papers (2020–2022)